|
1
|
Dougherty PM, Cata JP, Burton AW, Vu K and
Weng HR: Dysfunction in multiple primary afferent fiber subtypes
revealed by quantitative sensory testing in patients with chronic
vincristine-induced pain. J Pain Symptom Manage. 33:166–179. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dworkin RH, O'Connor AB, Audette J, Baron
R, Gourlay GK, Haanpää ML, Kent JL, Krane EJ, Lebel AA, Levy RM, et
al: Recommendations for the pharmacological management of
neuropathic pain: An overview and literature update. Mayo Clin
Proc. 85 Suppl 3:S3–S14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee J and Nandi P: Improving the
management of neuropathic pain. Practitioner. 254:27–30, 3.
2010.PubMed/NCBI
|
|
4
|
Kim YS, Park HJ, Kim TK, Moon DE and Lee
HJ: The effects of Ginkgo biloba extract EGb 761 on mechanical and
cold allodynia in a rat model of neuropathic pain. Anesth Analg.
108:1958–1963. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nurmikko TJ, Serpell MG, Hoggart B, Toomey
PJ, Morlion BJ and Haines D: Sativex successfully treats
neuropathic pain characterised by allodynia: A randomised,
double-blind, placebo-controlled clinical trial. Pain. 133:210–220.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ellis RJ, Toperoff W, Vaida F, van den
Brande G, Gonzales J, Gouaux B, Bentley H and Atkinson JH: Smoked
medicinal cannabis for neuropathic pain in HIV: A randomized,
crossover clinical trial. Neuropsychopharmacology. 34:672–680.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Zhang Q, Zhang Z, Song H and Li P:
Potential antioxidant and anticoagulant capacity of low molecular
weight fucoidan fractions extracted from Laminaria japonica. Int J
Biol Macromol. 46:6–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aisa Y, Miyakawa Y, Nakazato T, Shibata H,
Saito K, Ikeda Y and Kizaki M: Fucoidan induces apoptosis of human
HS-sultan cells accompanied by activation of caspase-3 and
down-regulation of ERK pathways. Am J Hematol. 78:7–14. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu CY, Zhang GP and Zhao YT: Fucoidan
attenuates the existing allodynia and hyperalgesia in a rat model
of neuropathic pain. Neurosci Lett. 571:66–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
National Institutes of Health (NIH), .
Office of Laboratory Animal Welfare (OLAW). http://olaw.nih.govMay 20–2016.
|
|
11
|
Siau C and Bennett GJ: Dysregulation of
cellular calcium homeostasis in chemotherapy-evoked painful
peripheral neuropathy. Anesth Analg. 102:1485–1490. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chaplan SR, Bach FW, Pogrel JW, Chung JM
and Yaksh TL: Quantitative assessment of tactile allodynia in the
rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smith GD, Harrison SM, Birch PJ, Elliott
PJ, Malcangio M and Bowery NG: Increased sensitivity to the
antinociceptive activity of (+/−)-baclofen in an animal model of
chronic neuropathic, but not chronic inflammatory hyperalgesia.
Neuropharmacology. 33:1103–1108. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dirig DM and Yaksh TL: Intrathecal
baclofen and muscimol, but not midazolam, are antinociceptive using
the rat-formalin model. J Pharmacol Exp Ther. 275:219–227.
1995.PubMed/NCBI
|
|
15
|
Thibault K, Calvino B, Rivals I, Marchand
F, Dubacq S, McMahon SB and Pezet S: Molecular mechanisms
underlying the enhanced analgesic effect of oxycodone compared to
morphine in chemotherapy-induced neuropathic pain. PLoS One.
9:e912972014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brenowitz S, David J and Trussell L:
Enhancement of synaptic efficacy by presynaptic GABA(B) receptors.
Neuron. 20:135–141. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang JH, Hwang KS, Kim JU, Choi IC, Park
PH and Han SM: The interaction between intrathecal neostigmine and
GABA receptor agonists in rats with nerve ligation injury. Anesth
Analg. 93:1297–1303. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Slonimski M, Abram SE and Zuniga RE:
Intrathecal baclofen in pain management. Reg Anesth Pain Med.
29:269–276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bai HP, Liu P, Wu YM, Guo WY, Guo YX and
Wang XL: Activation of spinal GABAB receptors normalizes
N-methyl-D-aspartate receptor in diabetic neuropathy. J Neurol Sci.
341:68–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XY, Zhang GF, Dong L, Wang X, Sun H,
Shen J, Li W and Xu J: Repeated administration of mirtazapine
attenuates oxaliplatin-induced mechanical allodynia and spinal NR2B
up-regulation in rats. Neurochem Res. 38:1973–1979. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McCarson KE, Ralya A, Reisman SA and Enna
SJ: Amitriptyline prevents thermal hyperalgesia and modifications
in rat spinal cord GABA(B) receptor expression and function in an
animal model of neuropathic pain. Biochem Pharmacol. 71:196–202.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Castro-Lopes JM, Malcangio M, Pan BH and
Bowery NG: Complex changes of GABAA and GABAB receptor binding in
the spinal cord dorsal horn following peripheral inflammation or
neurectomy. Brain Res. 679:289–297. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Engle MP, Gassman M, Sykes KT, Bettler B
and Hammond DL: Spinal nerve ligation does not alter the expression
or function of GABA(B) receptors in spinal cord and dorsal root
ganglia of the rat. Neuroscience. 138:1277–1287. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang XL, Zhang Q, Zhang YZ, Liu YT, Dong
R, Wang QJ and Guo YX: Downregulation of GABAB receptors in the
spinal cord dorsal horn in diabetic neuropathy. Neurosci Lett.
490:112–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCarson KE and Enna SJ: GABA
pharmacology: The search for analgesics. Neurochem Res.
39:1948–1963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thomas DA, Navarrete IM, Graham BA,
McGowan MK and Hammond DL: Antinociception produced by systemic
R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered
to the spinal cord or ventromedial medulla of rats. Brain Res.
718:129–137. 1996. View Article : Google Scholar : PubMed/NCBI
|
